{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-237191","form_type":"8-K","ticker":"SPRY","cik":"0001671858","company_name":"ARS Pharmaceuticals, Inc.","filed_at":"2024-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.178405+00:00","generated_at":"2026-05-30T14:37:03.074954+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ARS Pharma enters long-term supply agreement for neffy glass microvials through 2035","bullets":["Upfront payment of €3 million to Nuova Ompi for glass microvial supply.","Supplier must establish manufacturing force and capabilities to meet obligations.","Annual minimum purchase quantities and capped annual price adjustments specified.","Supply agreement expires December 31, 2035; termination for breach or reasonable business reasons."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-237191","json":"https://secwatch.observer/filing/0001193125-24-237191.json","markdown":"https://secwatch.observer/filing/0001193125-24-237191.md","text":"https://secwatch.observer/filing/0001193125-24-237191.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671858/000119312524237191/0001193125-24-237191-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671858/000119312524237191/d902443d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T14:37:03.074954+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}